ICICI Pru P H D Fund Direct IDCW
Summary Info
Fund Name
: ICICI Prudential Mutual Fund
Scheme Name
: ICICI Pru P H D Fund Direct IDCW
AMC
: ICICI Prudential Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 25-Jun-2018
Fund Manager
: Dharmesh Kakkad
Net Assets (Rs. cr)
: 6161.81
ICICI Pru P H D Fund Direct IDCW - Nav Details
Nav Date
: 17-Sep-2025
NAV [Rs.]
: 26.47
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: 1.00% - If units purchased or switched in from another scheme of the fund are redeemed or switched out within 18 months from the date of allotment Nil - If units purchased or switched in from another scheme of the fund are redeemed or switched out after 18 months from the date of allotment
ICICI Pru P H D Fund Direct IDCW- NAV Chart
ICICI Pru P H D Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 0.99 | 0.83 | 4.8 | 16.11 | 4.84 | 30.43 | 21.55 | 22.82 |
| Category Avg | 0.35 | 0.42 | 3.84 | 12.47 | 0.29 | 25.22 | 18.51 | 16.6 |
| Category Best | 1.3 | 4.07 | 6.64 | 16.98 | 9.75 | 30.53 | 21.58 | 34.23 |
| Category Worst | -0.33 | -0.78 | 1.29 | 9.11 | -10.57 | 21.26 | 14.05 | -2.28 |
ICICI Pru P H D Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
05-Aug-202520.50
ICICI Pru P H D Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
Hikal7,00,009
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 11.70 | 4523560 | 721.28 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.47 | 4633059 | 583.81 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.23 | 927926 | 568.95 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 7.39 | 2866624 | 455.62 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 6.52 | 3912690 | 402.18 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.44 | 1769639 | 335.32 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 4.00 | 465164 | 246.69 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.50 | 873005 | 215.75 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 3.21 | 5680217 | 197.87 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.87 | 947263 | 177.28 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.80 | 1761233 | 172.78 |
| Equity | Syngene Intl. | Healthcare Services | 2.17 | 2142146 | 134.07 |
| Equity | Medi Assist Ser. | Insurance | 1.77 | 2164815 | 109.49 |
| Equity | Alembic Pharma | Pharmaceuticals & Biotechnology | 1.63 | 1074403 | 100.66 |
| Equity | Metropolis Healt | Healthcare Services | 1.56 | 441872 | 96.70 |
| Equity | Thyrocare Tech. | Healthcare Services | 1.53 | 747474 | 94.57 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.51 | 180970 | 93.30 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 1.39 | 1052636 | 86.11 |
| Equity | Windlas Biotech | Pharmaceuticals & Biotechnology | 1.38 | 857651 | 85.62 |
| Equity | Sagility India | It - Services | 1.35 | 19054646 | 83.59 |
| Equity | Shilpa Medicare | Pharmaceuticals & Biotechnology | 1.32 | 963149 | 81.50 |
| Equity | Medplus Health | Retailing | 1.28 | 937074 | 78.89 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 1.18 | 378822 | 72.88 |
| Equity | Aarti Drugs | Pharmaceuticals & Biotechnology | 1.17 | 1542690 | 72.43 |
| Equity | Fine Organic | Chemicals & Petrochemicals | 1.14 | 150243 | 70.52 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.11 | 400000 | 68.97 |
| Equity | Star Health Insu | Insurance | 1.10 | 1519437 | 67.89 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.00 | 445701 | 62.10 |
| Equity | FDC | Pharmaceuticals & Biotechnology | 0.88 | 1197689 | 54.82 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 0.88 | 105676 | 54.79 |
| Equity | P & G Health Ltd | Pharmaceuticals & Biotechnology | 0.80 | 78012 | 49.69 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.75 | 55021 | 46.55 |
| Equity | Yatharth Hospit. | Healthcare Services | 0.74 | 661746 | 45.99 |
| Equity | Senores Pharma. | Pharmaceuticals & Biotechnology | 0.71 | 640883 | 44.23 |
| Equity | SPARC | Pharmaceuticals & Biotechnology | 0.63 | 2790872 | 39.09 |
| Equity | Advanced Enzyme | Pharmaceuticals & Biotechnology | 0.29 | 521768 | 18.05 |
| Equity | Hikal | Pharmaceuticals & Biotechnology | 0.28 | 700009 | 17.85 |
| Derivative Investments | |||||
| Derivatives | Cash Margin - Derivatives | -/- | 0.13 | 0 | 8.40 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 3.62 | 0 | 223.45 |
| Net CA & Others | Net CA & Others | -/- | 0.35 | 0 | 21.90 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
ICICI Prudential Mutual Fund
Incorporation Date:
22-Jun-1993
Total Assets Managed (Cr.):
9,83,726.26
Trustee/s:
Mr. P.H. Ravikumar, Mr. Lakshman Kumar Mylava, ICICI Prudential Trust Lt
Chairman:
NA
CEO / MD:
Mr. Nimesh Shah
CIO:
NA
President:
NA
Director/s:
Mr. Vijay Thacker, Mr. Nimesh Shah, Ms. Vibha Paul Rishi, Ms.Anubhuti Sanghai
Compliance Officer/s:
NA
Investor Service Officer/s:
Rajen Kotak
Fund Manager/s:
Dharmesh Kakkad
Auditors:
S.R.Batliboi & Co. LLP
OTHER INFORMATION
Registered Office:
One BKC, A-Wing, 13th Floor, Bandra Kurla Complex, Mumbai 400051
Contact Nos:
022 26525000
Fax:
022 26528100
Email:
Website:
